Sex differences in plasma p-tau181 associations with Alzheimer’s disease biomarkers, cognitive decline, and clinical progression
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1476-5578
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Sex differences in plasma p-tau181 associations with Alzheimer’s disease biomarkers, cognitive decline, and clinical progression ; day:29 ; month:6 ; year:2022 ; pages:1-9
Molecular psychiatry ; (29.6.2022), 1-9
- Creator
-
Tsiknia, Amaryllis A.
Edland, Steven D.
Sundermann, Erin E.
Reas, Emilie T.
Brewer, James B.
Galasko, Douglas
Banks, Sarah J.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1038/s41380-022-01675-8
- URN
-
urn:nbn:de:101:1-2022082021035828730709
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:30 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Tsiknia, Amaryllis A.
- Edland, Steven D.
- Sundermann, Erin E.
- Reas, Emilie T.
- Brewer, James B.
- Galasko, Douglas
- Banks, Sarah J.
- SpringerLink (Online service)
Other Objects (12)
Predicting progression and cognitive decline in amyloid-positive patients with Alzheimer’s disease
Biomarkers in Alzheimer’s disease
Diagnostic and progression biomarkers in cerebrospinal fluid of Alzheimer’s disease patients
Alzheimer’s and neurodegenerative disease biomarkers in blood predict brain atrophy and cognitive decline
Blood biomarkers for Alzheimer’s disease
Neuroimaging Biomarkers for Alzheimer’s Disease
Conflicting cerebrospinal fluid biomarkers and progression to dementia due to Alzheimer’s disease
Structural imaging biomarkers of Alzheimer's disease : predicting disease progression
Short- and Long-Term Functional Connectivity Differences Associated with Alzheimer’s Disease Progression
Association of lysophosphatidic acids with cerebrospinal fluid biomarkers and progression to Alzheimer’s disease
Exploring easily accessible neurophysiological biomarkers for predicting Alzheimer’s disease progression: a systematic review
Current state of Alzheimer’s fluid biomarkers
Predicting progression and cognitive decline in amyloid-positive patients with Alzheimer’s disease
Biomarkers in Alzheimer’s disease
Diagnostic and progression biomarkers in cerebrospinal fluid of Alzheimer’s disease patients
Alzheimer’s and neurodegenerative disease biomarkers in blood predict brain atrophy and cognitive decline
Blood biomarkers for Alzheimer’s disease
Neuroimaging Biomarkers for Alzheimer’s Disease
Conflicting cerebrospinal fluid biomarkers and progression to dementia due to Alzheimer’s disease
Structural imaging biomarkers of Alzheimer's disease : predicting disease progression
Short- and Long-Term Functional Connectivity Differences Associated with Alzheimer’s Disease Progression
Association of lysophosphatidic acids with cerebrospinal fluid biomarkers and progression to Alzheimer’s disease
Exploring easily accessible neurophysiological biomarkers for predicting Alzheimer’s disease progression: a systematic review
Current state of Alzheimer’s fluid biomarkers
Predicting progression and cognitive decline in amyloid-positive patients with Alzheimer’s disease
Biomarkers in Alzheimer’s disease
Diagnostic and progression biomarkers in cerebrospinal fluid of Alzheimer’s disease patients
Alzheimer’s and neurodegenerative disease biomarkers in blood predict brain atrophy and cognitive decline
Blood biomarkers for Alzheimer’s disease
Neuroimaging Biomarkers for Alzheimer’s Disease
Conflicting cerebrospinal fluid biomarkers and progression to dementia due to Alzheimer’s disease
Structural imaging biomarkers of Alzheimer's disease : predicting disease progression
Short- and Long-Term Functional Connectivity Differences Associated with Alzheimer’s Disease Progression
Association of lysophosphatidic acids with cerebrospinal fluid biomarkers and progression to Alzheimer’s disease
Exploring easily accessible neurophysiological biomarkers for predicting Alzheimer’s disease progression: a systematic review